These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31188743)

  • 1. Red blood cells participate in reverse cholesterol transport by mediating cholesterol efflux of high-density lipoprotein and apolipoprotein A-I from THP-1 macrophages.
    Lai SJ; Ohkawa R; Horiuchi Y; Kubota T; Tozuka M
    Biol Chem; 2019 Nov; 400(12):1593-1602. PubMed ID: 31188743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages.
    Uto-Kondo H; Ayaori M; Ogura M; Nakaya K; Ito M; Suzuki A; Takiguchi S; Yakushiji E; Terao Y; Ozasa H; Hisada T; Sasaki M; Ohsuzu F; Ikewaki K
    Circ Res; 2010 Mar; 106(4):779-87. PubMed ID: 20075335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.
    Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A
    Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
    Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
    FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart JC; Ailhaud G; Assmann G
    J Biol Chem; 1993 Feb; 268(4):2616-22. PubMed ID: 8428938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis.
    Kudinov VA; Torkhovskaya TI; Zakharova TS; Morozevich GE; Artyushev RI; Zubareva MY; Markin SS
    Biomed Pharmacother; 2021 Sep; 141():111900. PubMed ID: 34328100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the cholesterol efflux of apolipoprotein E-containing high-density lipoprotein in THP-1 cells.
    Horiuchi Y; Ohkawa R; Lai SJ; Yamazaki A; Ikoma H; Yano K; Kameda T; Tozuka M
    Biol Chem; 2019 Jan; 400(2):209-218. PubMed ID: 30210053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport.
    Jin FY; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2020-8. PubMed ID: 9351367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages.
    Matsuyama A; Sakai N; Hiraoka H; Hirano K; Yamashita S
    J Lipid Res; 2006 Jan; 47(1):78-86. PubMed ID: 16251720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
    Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L
    J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.
    Borja MS; Ng KF; Irwin A; Hong J; Wu X; Isquith D; Zhao XQ; Prazen B; Gildengorin V; Oda MN; Vaisar T
    J Lipid Res; 2015 Oct; 56(10):2002-9. PubMed ID: 26254308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases-3, -7, and -12, but not -9, reduce high density lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein A-I. Parallel losses of pre-beta particles and the high affinity component of efflux.
    Lindstedt L; Saarinen J; Kalkkinen N; Welgus H; Kovanen PT
    J Biol Chem; 1999 Aug; 274(32):22627-34. PubMed ID: 10428843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells.
    Banka CL; Black AS; Curtiss LK
    J Biol Chem; 1994 Apr; 269(14):10288-97. PubMed ID: 7511599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol.
    Avdulov NA; Chochina SV; Igbavboa U; Wood WG
    Biochemistry; 2000 Aug; 39(34):10599-606. PubMed ID: 10956052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
    Murakami H; Tanabe J; Tamasawa N; Matsumura K; Yamashita M; Matsuki K; Murakami H; Matsui J; Suda T
    Diabetes Res Clin Pract; 2013 Jan; 99(1):30-8. PubMed ID: 23137417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-sensing high-throughput ApoA-I assays.
    Niedziela-Majka A; Lad L; Chisholm JW; Lagpacan L; Schwartz K; Hung M; Jin D; Fung W; Brendza KM; Liu X; Pagratis N; Sakowicz R
    J Biomol Screen; 2012 Sep; 17(8):1050-61. PubMed ID: 22811478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
    Liu L; Bortnick AE; Nickel M; Dhanasekaran P; Subbaiah PV; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 2003 Oct; 278(44):42976-84. PubMed ID: 12928428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
    Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.